Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001104659-23-042221

Chief Executive Officer acquired 30,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Chan Phillip P. Chief Executive Officer 2023-04-03 Option exercise +30,500 $2.88 $87,688 927,779 D
Derivatives
Chan Phillip P. Chief Executive Officer 2023-04-03 Option exercise · Stock Option (right to buy) −30,500 0 D
Loading xslF345X04/tm2311822d1_4.xml…